Free tool

Stocks listed on Nasdaq GS

We cover 20 companies listed on Nasdaq GS. The median market value in the group is $68.17M. Across the group, the median move over the past trading day is −0.62%. 40% of the 20 with a 200-day average trade above it. Price change over the past year runs from −75.5% to +108.8% across the middle 80 percent of the group, with a median of −32.5%.

Other lists in this group

Table

20 of 1,279 companies match these filters.Clear filters

TickerCompanyPrice1M returnYTD return1Y return
AMGNAmgen Inc.$440.34+12.02%+36.35%+56.24%
ATRAAtara Biotherapeutics, Inc.$9.38+20.10%−47.21%−24.05%
CVRXCVRx, Inc.$3.27−33.94%−53.94%−56.75%
GOSSGossamer Bio, Inc.$0.17−15.17%−93.96%−92.93%
DHDefinitive Healthcare Corp.$0.79+11.75%−66.73%−80.44%
OMOutset Medical, Inc.$4.25−9.96%+14.86%−69.56%
PLRXPliant Therapeutics, Inc.$1.16+8.41%−7.20%−31.36%
SPROSpero Therapeutics, Inc.$1.22+2.09%−48.09%−38.38%
XBITXBiotech Inc.$2.31+1.76%−2.94%−33.62%
PMVPPMV Pharmaceuticals, Inc.$1.31+19.09%+6.50%−7.75%
BOLDBoundless Bio, Inc.$2.92+18.02%+138.93%+155.70%
MCRBSeres Therapeutics, Inc.$4.76−0.83%−68.58%−74.79%
MGXMetagenomi Therapeutics, Inc.$1.22+0.83%−26.95%−34.41%
KPTIKaryopharm Therapeutics Inc. Common Stock$1.96−72.36%−72.74%−74.90%
PETSPetMed Express, Inc.$1.79−10.95%−45.76%−43.35%
KYNBKyntra Bio, Inc.$8.11+16.20%−11.52%−22.66%
QNCXQuince Therapeutics, Inc.$31.31+61.64%+4.37%+100.71%
NXTCNextCure, Inc.$5.83+7.56%−56.10%+11.37%
TXMDTherapeuticsMD, Inc.$2.28+10.68%+38.18%+103.57%
TRIBTrinity Biotech plc$9.59−22.97%+1178.67%+547.97%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse